perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
Published 3 years ago • 577 plays • Length 5:49Download video MP4
Download video MP3
Similar videos
-
5:00
olympia: adjuvant olaparib delays recurrence of brca-mutant breast cancer | judy garber
-
2:44
olympia: adjuvant olaparib in gbrcam, her2-negative, high-risk, early breast cancer
-
0:49
dr. tung discusses the role of olaparib in breast cancer
-
2:58
olympia: adjuvant olaparib following chemo significantly improves idfs
-
2:18
the importance of the olympia trial for breast cancer patients
-
3:09
breast cancer breakthrough - prof andrew tutt on the olympia trial
-
8:09
olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...
-
1:19:32
dr nyjon eccles - changing the game in breast cancer risk
-
1:15
dr. robson on the toxicity profile of olaparib in breast cancer
-
3:05
exploring the use of olaparib in advanced breast cancer
-
9:13
tbcrc 048: olaparib monotherapy in metastatic breast cancer
-
1:36
olympia trial
-
5:43
using olaparib in gbrca1/2 breast cancer
-
10:37
gs4-09. quality of life results from olympia:
-
1:18
dr. robson on exploratory analysis from olympiad in breast cancer
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
3:14
parp inhibitor staves off recurrence in early brca-mutant breast cancer - medpage today
-
3:50
olaparib beneficial for brca-mutated her2-negative breast cancer
-
1:45
the olympia clinical trial - results